FDA's Young on Delaney
In a discussion of the increased burden on the agency related to food "scares" such as the recent uproar over trace amounts of Alar in apples, FDA Commissioner Young told the House Appropriations/Agriculture Subcommittee at an April 10 hearing that Congress must "deal with the Delaney issue." He also cited FD&C Red 3 as an example of the "terrible problem" caused by the Delaney Clause. Under a de minimis analysis, the color additive is "safe," Young said, while a rigid interpretation of the law appears to dictate otherwise.
You may also be interested in...
Notified bodies’ efforts to enhance a harmonized approach to remote audits have failed, raising questions about whether there is any avenue left to get vital devices certified by the 26 May EU MDR deadline.
As Amneal’s generics segment sees significant growth, the company has revealed plans to launch new products and expand in new markets. “We are extremely proud of the progress our company has made since we re-joined as leaders of Amneal,” said Chirag and Chintu Patel, co-CEOs of Amneal.
Schemes and funding to support growth in the life sciences and medtech sectors featured in the UK government’s spring budget on 3 March.